COPD

The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year.

The digital respiratory health company says this deal and clearance now give it access to 90% of the U.S. asthma and COPD market.

Oxfordshire-based Satellite Applications Catapult has already been working with the NHS Arden & GEM CSU for the past year and a half.

The Loop System continuously collects and analyzes health data to warn providers of potential deterioration. The company says it has already inked a deal with a major health system.

At the MEDinIsrael conference in Tel Aviv, Director of Analytics and Big Data Dr. Lena Granovsky talked about technology, big data, and analytics' growing role at the company.

Digital therapeutics company Kaia Health has unveiled a feasibility study to examine the impact of its digital therapeutic treatment of Chronic Obstructive Pulmonary Disease (COPD) on Japan’s ageing population.

While connected devices currently reign supreme, authors of the report see a market opportunity for new players offering a purely digital service.

Users will be able to make refill requests, locate pharmacies, and even chat with a pharmacist without leaving Propeller's app.

The prescription device detects each use and records it to a paired mobile app. 

Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma.